{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "9361579",
  "DateCompleted": {
    "Year": "1997",
    "Month": "11",
    "Day": "25"
  },
  "DateRevised": {
    "Year": "2013",
    "Month": "11",
    "Day": "21"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0003-9926",
      "JournalIssue": {
        "Volume": "157",
        "Issue": "20",
        "PubDate": {
          "Year": "1997",
          "Month": "Nov",
          "Day": "10"
        }
      },
      "Title": "Archives of internal medicine",
      "ISOAbbreviation": "Arch Intern Med"
    },
    "ArticleTitle": "A meta-analysis of zinc salts lozenges and the common cold.",
    "Pagination": {
      "StartPage": "2373",
      "EndPage": "2376",
      "MedlinePgn": "2373-6"
    },
    "Abstract": {
      "AbstractText": [
        "In the United States, the common cold has been estimated to cost more than $3.5 billion a year. Despite several randomized clinical trials, the effect of treating colds with zinc salts lozenges remains uncertain because of conflicting results.",
        "To conduct a meta-analysis of published randomized clinical trials on the use of zinc salts lozenges in colds using a random effects model.",
        "Eight clinical trials of treating adults with zinc salts lozenges were identified. After excluding 2 studies that used nasal inoculation of rhinovirus, 6 trials were combined and analyzed. The summary odds ratio for the presence of any cold symptoms at 7 days was 0.50 (95% confidence interval, 0.19-1.29).",
        "Despite numerous randomized trials, the evidence for effectiveness of zinc salts lozenges in reducing the duration of common colds is still lacking."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Madigan Army Medical Center, Tacoma, Wash, USA."
          }
        ],
        "LastName": "Jackson",
        "ForeName": "J L",
        "Initials": "JL"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Peterson",
        "ForeName": "C",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Lesho",
        "ForeName": "E",
        "Initials": "E"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Meta-Analysis"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Arch Intern Med",
    "NlmUniqueID": "0372440",
    "ISSNLinking": "0003-9926"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "J41CSQ7QDS",
      "NameOfSubstance": "Zinc"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Administration, Oral"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [
        "prevention & control",
        "virology"
      ],
      "DescriptorName": "Common Cold"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Double-Blind Method"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Incidence"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Odds Ratio"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Randomized Controlled Trials as Topic"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Reproducibility of Results"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Treatment Outcome"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Zinc"
    }
  ]
}